According to a new study, patients with aggressive rheumatoid arthritis (RA) have lower levels of non-esterified fatty acids, which coincide with an enhanced Th1 response. Researchers suggest that lower EPA and DHA at the onset of RA may exacerbate inflammation, and fatty acids may become a novel therapeutic target for the disease…
![](https://www.the-rheumatologist.org/wp-content/uploads/2016/06/Flasks_gopixa_Shutterstock_500x270-150x150.jpg)